Innoviva, Inc. (INVA) Earnings History
Annual and quarterly earnings data from 2002 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 72.3% | 38.5% | 63.8% |
| 2024 | 89.8% | 46.5% | 6.5% |
| 2023 | 86.3% | 36.7% | 57.9% |
| 2022 | 95.8% | -11.2% | 64.6% |
| 2021 | 100.0% | 95.7% | 67.8% |
Download Data
Export INVA earnings history in CSV or JSON format
Free sign-in required to download data
Innoviva, Inc. (INVA) Earnings Overview
As of March 5, 2026, Innoviva, Inc. (INVA) reported trailing twelve-month net income of $271M, reflecting +8.2% year-over-year growth. The company earned $3.18 per diluted share over the past four quarters, with a net profit margin of 0.6%.
Looking at the long-term picture, INVA's 5-year EPS compound annual growth rate (CAGR) stands at +10.3%, showing solid earnings momentum. The company achieved its highest annual net income of $395M in fiscal 2018.
Innoviva, Inc. maintains positive profitability with a gross margin of 0.7%, operating margin of 0.4%, and net margin of 0.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including RPRX ($765M net income, 0.3% margin), LGND ($49M net income, -0.0% margin), BTX (N/A net income, 0.9% margin), INVA has outperformed on profitability metrics. Compare INVA vs RPRX →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
24 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $271M | +1059.2% | $164M | $3.30 | 63.8% | 38.5% |
| 2024 | $23M | -87.0% | $167M | $0.36 | 6.5% | 46.5% |
| 2023 | $180M | -16.0% | $114M | $2.20 | 57.9% | 36.7% |
| 2022 | $214M | -19.5% | -$37M | $2.37 | 64.6% | -11.2% |
| 2021 | $266M | +18.5% | $375M | $2.87 | 67.8% | 95.7% |
| 2020 | $224M | +42.7% | $321M | $2.02 | 66.6% | 95.3% |
| 2019 | $157M | -60.2% | $246M | $1.43 | 60.3% | 94.4% |
| 2018 | $395M | +194.5% | $238M | $3.48 | 151.4% | 91.3% |
| 2017 | $134M | +125.3% | $184M | $1.17 | 61.8% | 84.5% |
| 2016 | $60M | +417.4% | $109M | $0.53 | 44.6% | 81.6% |
See INVA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs INVA Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare INVA vs LLY
See how INVA stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is INVA growing earnings?
INVA EPS stands at $3.18, with +8.2% growth matching the 5-year CAGR of +10.3%. TTM net income is $271M. Earnings trajectory remains consistent.
What are INVA's profit margins?
Innoviva, Inc. net margin is +0.6%, with operating margin at +0.4%. Below-average margins reflect competitive or cost pressures.
How consistent are INVA's earnings?
INVA earnings data spans 2002-2025. The current earnings trend is +8.2% YoY. Historical data enables comparison across business cycles.